Clinical trials

  • mepolizumab for Severe asthma|Eosinophilic asthma
  • JNJ-95437446 for Non-small cell lung cancer | Colorectal cancer | Squamous cell carcinoma of head and neck
  • TALAZOPARIB for Metastatic castration-resistant prostate cancer
  • IANALUMAB for Rheumatoid arthritis|Sjögren's syndrome|Systemic lupus erythematosus
  • LINAPRAZAN GLURATE for Erosive esophagitis due to gastroesophageal reflux disease (GERD)
  • ABELACIMAB for Atrial fibrillation
  • 177LU-FAP-2286 for Non-small cell lung cancer | Pancreatic ductal adenocarcinoma | Metastatic breast cancer
  • Panitumumab for Metastatic colorectal cancer (RAS/BRAF wild-type)
  • IFINATAMAB DERUXTECAN for Small cell lung cancer
  • Clinical trial in Liver transplant | Ischemia-reperfusion injury
  • BP1.7881A for Eosinophilic esophagitis
  • DURVALUMAB for Endometrial cancer | Advanced or recurrent endometrial cancer